Clinical Trial Update: Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of goserelin (Zoladex) in spinal bulbar muscular atrophy (Kennedy's disease) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Bulbar Muscular Atrophy

Drugs mentioned

• Goserelin (Zoladex) (goserelin)

Snippet

Sponsor: Ramathibodi Hospital | Conditions: Spinobulbar Muscular Atrophy, Kennedy's Disease | Phase 4 | Status: COMPLETED